Novel Treatment Delivery of ECAP-controlled Closed-loop SCS for Chronic Pain
RecruitingNot applicableNCT04662905
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
The purpose of this study is to test and evaluate novel treatment delivery of ECAP-controlled closed loop SCS through the incorporation of new software and/or hardware features for patients with the Evoke System.
Study details
- Official title
- A Prospective, Multicentre, Single-arm Feasibility Study Examining Novel Treatment Delivery of the Evoke Spinal Cord Stimulator (SCS) System to Treat Patients With Chronic Pain of the Trunk and/or Limbs
- Conditions
- Interventions
- Sponsor
- Saluda Medical Pty Ltd
- Start date
- 2020-12-15
- Primary completion
- 2029-01-01
- Sex
- All
- Age range
- from 18 Years
- Results posted
- No results posted in this snapshot
- Countries
- Australia
- Total sites listed
- 25
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * 1\. Subject has undergone trial implant or is planning to be implanted with the Evoke System within its approved indication. * 2\. Subject is willing and capable of giving informed consent and able to comply with study-related requirements. Exclusion Criteria: N/A
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT04662905